glp-1 lasker Obesity-drug pioneers win prestigious Award for medical science GLP-1 Support Supplement for Appetite

A phase 2 trial of semaglutide 2.4 mg in 71 cirrhotic patients confirmed an acceptable safety profile without significant decompensation events, although the primary histological endpoint was not met, possibly due to the limited ability of antifibrotic remodeling to achieve biopsy-detectable fibrosis stage improvement in established cirrhosis over 48 weeks [46]

doi:10.1210/en.2012-1610

Bagged salad or pre-washed cucumbers and baby carrots These are here for low-effort freshness, not because you need a giant salad

BMI requirements were increased to greater than 40 mg/kg2 or greater than 35 mg/kg2 with one more weight-related comorbidity